Conoscenti, Craig S
3 papers on CoChat
Most cited papers
- Verified
Rationale for and design of the Idiopathic Pulmonary Fibrosis–PRospective Outcomes (IPF-PRO) registry
O'Brien, E. C., Durheim, M. T., Gamerman, V., Garfinkel, S., Anstrom, K. J., Palmer, S. M., & Conoscenti, C. S. (2016) · BMJ Open Respiratory Research
Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisOccupational and environmental lung diseases
Cited by 75
- Verified
Design of the MIST study: a double-blind, randomised, placebo-controlled phase 2b trial of pirfenidone solution for inhalation in patients with progressive pulmonary fibrosis
Kolb, M., Corte, T. J., Feldman, J., Nathan, S. D., Reisner, C., Nair, D., Woodhead, F., Lazarus, H., & Conoscenti, C. (2025) · BMJ Open Respiratory Research
Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisInhalation and Respiratory Drug Delivery
Cited by 1
- Verified
Improved quality of life, reduced quantitative lung fibrosis in a trial of inhaled pirfenidone for idiopathic pulmonary fibrosis
Kim, G. H. J., Woodhead, F. A., Nair, D., Bao, H., Lazarus, H. M., Conoscenti, C. S., & Goldin, J. G. (2026) · BMC Pulmonary Medicine
Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisChronic Obstructive Pulmonary Disease (COPD) Research
Cited by 1
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free